GOSS
Gossamer Bio Inc
NASDAQ · Biotechnology
$2.26
-0.18 (-7.19%)
Open$2.48
Previous Close$2.44
Day High$2.50
Day Low$2.23
52W High$3.87
52W Low$0.76
Volume—
Avg Volume5.74M
Market Cap523.09M
P/E Ratio—
EPS$-0.69
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+1,112.8% upside
Current
$2.26
$2.26
Target
$27.41
$27.41
$18.46
$27.41 avg
$44.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 117.35M | 95.94M | 101.30M |
| Net Income | -57,840,914 | 13.15M | 13.02M |
| Profit Margin | -49.3% | 13.7% | 12.9% |
| EBITDA | -46,106,082 | 20.01M | 19.52M |
| Free Cash Flow | — | 11.25M | 11.45M |
| Rev Growth | — | +8.6% | -0.1% |
| Debt/Equity | 6.70 | 1.02 | 0.99 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |